The MOGA type of protein involved in cell adhesion. Present throughout myelin sheaths. Project is honored to be featured by Johns Hopkins Medicine in a recent article highlighting advances in understanding myelin oligodendrocyte glycoprotein antibody disease (MOGAD)Often referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease and the importance of specialized, collaborative care — particularly for children affected by this rare condition.
The article reflects the mission that has guided The MOGA type of protein involved in cell adhesion. Present throughout myelin sheaths. Project since its founding: improving awareness, accelerating research, increasing advocacy, and supporting individuals and families living with MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease . The organization was created by family members and advocates, inspired by children like Isabel and Sophia, whose experiences emphasize the urgent need for pediatric-focused research and education.
In the article, the author notes the evolving understanding of MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease and how recognition as a distinct disease has advanced in just a few years: “It is now clear that MOGAD was different from multiple sclerosisAn autoimmune disease that attacks healthy cells in the myelin, the protective sheath that surrounds nerves in the central nervous system (CNS) leading to neurological symptoms originating from the brain, spinal cord, and/or optic nerve., though it wouldn’t even have a name until 2018.” That same year, The MOGA type of protein involved in cell adhesion. Present throughout myelin sheaths. Project was created. This acknowledgement of MOGAD’s unique clinical identity speaks directly to the importance of The MOGA type of protein involved in cell adhesion. Present throughout myelin sheaths. Project’s work.
Founded by Julia Lefelar, alongside Amy Ednie and Kristina Lefelar, The MOGA type of protein involved in cell adhesion. Present throughout myelin sheaths. Project works in close partnership with leading clinicians, researchers, and medical centers — including Johns Hopkins Medicine — to advance understanding of MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease and improve outcomes for patients of all ages.
We are grateful to the Johns Hopkins team for shining a light onInflammation of the optic nerve that may be classified as unilateral (affecting one eye) or bilateral (affecting both eyes) that may result in vision changes, vision loss, and/or pain with eye movement. this work and for their continued commitment to pediatric neuroimmunology research and care.
This coverage joins a growing body of national and regional media attention highlighting the work of The MOGA type of protein involved in cell adhesion. Present throughout myelin sheaths. Project. Our efforts have also been featured by Mayo Clinic, The New York Times, The Washington Post, and local and national news outlets.
To explore more media coverage and learn how awareness, advocacy, and research are moving the field forward, visit our Press page.
